The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

The MAHA war on expertise leaves Americans ever more vulnerable to predators and scams, which in turn exacerbates a much ...

The US Food and Drug Administration will meet its drug approval targets this year despite cutting thousands of staff, the ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty discusses two new COVID vaccines ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

US growth likely to slow to 1.6% this year, hobbled by Trump's trade wars, OECD says. U.S. economic growth will slow to 1.6% this year from 2.8% last year as President ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...

The FDA is defending a decision to restrict access to a newly-approved low dose COVID vaccine from Moderna that the company ...

The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...